Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Red Violet | RDVT | Nov 27, 2024 | 36.49 | -1.24 |
RDDT | Nov 27, 2024 | 140.04 | +3.27 | |
Redfin | RDFN | Nov 27, 2024 | 9.66 | +0.52 |
RedHill Biopharma ADR | RDHL | Nov 27, 2024 | 7.96 | +0.63 |
Redwire | RDW | Nov 27, 2024 | 13.49 | -2.10 |
Redwood Trust | RWT-A | Nov 27, 2024 | 25.79 | -0.03 |
Redwood Trust | RWT | Nov 27, 2024 | 7.19 | +0.98 |
REE Automotive A | REE | Nov 27, 2024 | 7.70 | -1.66 |
Regal Rexnord | RRX | Nov 27, 2024 | 169.66 | -1.34 |
Regency Centers | REG | Nov 27, 2024 | 75.91 | +1.21 |
Regency Centers A Pref | REGCP | Nov 27, 2024 | 24.23 | +0.62 |
Regency Centers B Pref | REGCO | Nov 27, 2024 | 22.95 | +1.01 |
Regeneron Pharmaceuticals | REGN | Nov 27, 2024 | 754.87 | +0.24 |
REGENXBIO | RGNX | Nov 27, 2024 | 10.01 | +4.82 |
Regional Health Properties | RHE | Nov 27, 2024 | 1.70 | +5.70 |
Regional Health Properties A Pref | RHE-A | Nov 27, 2024 | 0.55 | -0.02 |
Regional Management | RM | Nov 27, 2024 | 30.84 | +0.39 |
Regions Financial | RF | Nov 27, 2024 | 27.25 | -0.22 |
Regions Financial B Pref | RF-B | Nov 27, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Nov 27, 2024 | 24.72 | +0.32 |
Regions Financial E Pref | RF-E | Nov 27, 2024 | 19.46 | +0.36 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Nov 27, 2024 | 26.06 | +0.42 |
Regis | RGS | Nov 27, 2024 | 24.36 | +5.68 |
Regulus Therapeutics | RGLS | Nov 27, 2024 | 1.64 | +7.19 |
Reinsurance Group of America | RGA | Nov 27, 2024 | 229.46 | -0.94 |
REIT Index ETF Vanguard | VNQ | Nov 27, 2024 | 98.60 | +0.64 |
Reitar Logtech | RITR | Nov 27, 2024 | 4.12 | 0.00 |
Rekor Systems | REKR | Nov 27, 2024 | 0.96 | -4.85 |
Relay Therapeutics | RLAY | Nov 27, 2024 | 4.80 | +0.84 |
Reliance | RS | Nov 27, 2024 | 322.58 | +0.21 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.